826 related articles for article (PubMed ID: 27370358)
21. Assisted reproductive technology use and outcomes among women with a history of cancer.
Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
[TBL] [Abstract][Full Text] [Related]
22. Season at the time of oocyte collection and frozen embryo transfer outcomes.
Leathersich SJ; Roche CS; Walls M; Nathan E; Hart RJ
Hum Reprod; 2023 Sep; 38(9):1714-1722. PubMed ID: 37407029
[TBL] [Abstract][Full Text] [Related]
23. Effect of oocyte donor stimulation on recipient outcomes: data from a US national donor oocyte bank.
Hipp HS; Gaskins AJ; Nagy ZP; Capelouto SM; Shapiro DB; Spencer JB
Hum Reprod; 2020 Apr; 35(4):847-858. PubMed ID: 32142582
[TBL] [Abstract][Full Text] [Related]
24. The number of oocytes retrieved during IVF: a balance between efficacy and safety.
Magnusson Å; Källen K; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2018 Jan; 33(1):58-64. PubMed ID: 29136154
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
[TBL] [Abstract][Full Text] [Related]
26. Comparison of two different oocyte vitrification methods: a prospective, paired study on the same genetic background and stimulation protocol.
Pujol A; Zamora MJ; Obradors A; Garcia D; Rodriguez A; Vassena R
Hum Reprod; 2019 Jun; 34(6):989-997. PubMed ID: 31116386
[TBL] [Abstract][Full Text] [Related]
27. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
[TBL] [Abstract][Full Text] [Related]
28. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
[TBL] [Abstract][Full Text] [Related]
29. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
Roustan A; Perrin J; Debals-Gonthier M; Paulmyer-Lacroix O; Agostini A; Courbiere B
Hum Reprod; 2015 Apr; 30(4):840-7. PubMed ID: 25740883
[TBL] [Abstract][Full Text] [Related]
30. Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial.
Beguería R; García D; Vassena R; Rodríguez A
Hum Reprod; 2019 May; 34(5):872-880. PubMed ID: 30927417
[TBL] [Abstract][Full Text] [Related]
31. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z
Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
[TBL] [Abstract][Full Text] [Related]
32. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
[TBL] [Abstract][Full Text] [Related]
33. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
[TBL] [Abstract][Full Text] [Related]
34. A multi-centre, retrospective case series of oocyte cryopreservation in unmarried women diagnosed with haematological malignancies.
Kato K; Ochi M; Nakamura Y; Kamiya H; Utsunomiya T; Yano K; Michikura Y; Hara T; Kyono K; Takeuchi K; Nakayama T; Iwamasa J; Mio Y; Kuramoto T; Nagata Y; Jo T; Asada Y; Ohishi H; Osada H; Yoshida H
Hum Reprod Open; 2021; 2021(1):hoaa064. PubMed ID: 33501384
[TBL] [Abstract][Full Text] [Related]
35. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
[TBL] [Abstract][Full Text] [Related]
36. IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patients.
Esmaeilian Y; Hela F; Bildik G; Akin N; İltumur E; Yusufoglu S; Yildiz CS; Keles İ; Vatansever D; Taskiran C; Yakin K; Oktem O
Hum Reprod; 2023 Jan; 38(1):113-124. PubMed ID: 36367834
[TBL] [Abstract][Full Text] [Related]
37. Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience.
Cardozo ER; Thomson AP; Karmon AE; Dickinson KA; Wright DL; Sabatini ME
J Assist Reprod Genet; 2015 Apr; 32(4):587-96. PubMed ID: 25595540
[TBL] [Abstract][Full Text] [Related]
38. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
39. Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.
Puy V; Dupeux M; Mayeur A; Grynberg M; Benoit A; Bendayan M; Zhegari F; Hesters L; Gallot V; Prevot S; Frydman N; Sonigo C
Hum Reprod; 2023 May; 38(5):860-871. PubMed ID: 36860186
[TBL] [Abstract][Full Text] [Related]
40. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
